stockrow
Friday 6 November 2026
Export INFU’s income statement to Excel — free account
InfuSystems Holdings, Inc.
INFU Healthcare Medical Devices
InfuSystems Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $143.4 million, up 6.36% from fiscal 2024.
- Revenue
- +2.59%
- EPS
- +33.3%
- Free cash flow
- −66.5%
- Total debt
- −22.5%
Quarter to June 2026, against a year earlier
13.73
0.17
+1.25%
Follow INFU
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
9.95% | 11.54% | 13.89% | 15.03% | |
Piotroski F-Score |
8 | 8 | 8 | 9 | |
| 5.41% | 6.49% | 7.80% | 8.61% | ||
ROIC |
8.96% | 10.10% | 10.56% | 10.55% | |
Return on Tangible Assets |
26.94% | 33.96% | 34.79% | 32.89% | |
Average Days of Receivables |
62.90 | 58.28 | 61.46 | 69.28 | |
Free Cash Flow per Share |
0.92 | 0.92 | 0.97 | 0.75 | |
Free Cash Flow |
18.76 | 19.03 | 19.62 | 15.14 | |
Capital Expenditures |
(6.45) | (5.38) | (3.98) | (8.23) | |
| Other line items | |||||
Cash ROIC |
24.25% | 23.75% | 24.37% | 18.80% | |
Accounts Receivable Turnover |
5.99 | 6.51 | 5.95 | 5.55 | |
Accounts Payable Turnover |
6.65 | 6.11 | 6.84 | 6.67 | |
Inventory Turnover |
10.25 | 10.59 | 10.33 | 10.90 | |
Average Days of Payables |
58.10 | 62.55 | 57.08 | 53.74 | |
Days of Inventory on Hand |
32.40 | 31.16 | 34.56 | 33.03 | |
Tax Rate |
(0.41) | (0.38) | (0.33) | (0.30) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
47.68% | 47.67% | 47.69% | 48.20% | |
Share Based Compensation of Revenue |
3.03% | 3.04% | 3.15% | 3.54% | |
Interest Coverage |
7.73 | 9.18 | 10.58 | 12.06 | |
Operating CF/Net income |
4.56 | 3.68 | 2.98 | 2.74 | |
Depreciation/Fixed assets |
3.68 | 3.98 | 4.14 | 4.43 | |
Capex/Depreciation |
(0.48) | (0.40) | (0.30) | (0.62) | |
Revenue per Share |
6.91 | 6.94 | 7.05 | 7.14 | |
Operating CF per Share |
1.24 | 1.18 | 1.17 | 1.16 | |
Capex per Share |
(0.32) | (0.26) | (0.20) | (0.41) | |
Capex to Sales |
0.05 | 0.04 | 0.03 | 0.06 |
Columns are period end dates